The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key markets has introduced considerable volatility. Investors are now assessing the consequences of lower-c… Read More